Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/73312
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Intracellular retention of ABL kinase inhibitors determines commitment to apoptosis in CML cells |
Author: | Lipka, D. Wagner, M. Dziadosz, M. Schnoder, T. Heidel, F. Schemionek, M. Vaz de Melo, J. Kindler, T. Muller-Tidow, C. Koschmieder, S. Fischer, T. |
Citation: | PLoS One, 2012; 7(7):1-16 |
Publisher: | Public Library of Science |
Issue Date: | 2012 |
ISSN: | 1932-6203 1932-6203 |
Editor: | Fields, A.P. |
Statement of Responsibility: | Daniel B. Lipka, Marie-Christine Wagner, Marek Dziadosz, Tina Schnöder, Florian Heidel, Mirle Schemionek, Junia V. Melo, Thomas Kindler, Carsten Müller-Tidow, Steffen Koschmieder and Thomas Fischer |
Abstract: | Clinical development of imatinib in CML established continuous target inhibition as a paradigm for successful tyrosine kinase inhibitor (TKI) therapy. However, recent reports suggested that transient potent target inhibition of BCR-ABL by highdose TKI (HD-TKI) pulse-exposure is sufficient to irreversibly commit cells to apoptosis. Here, we report a novel mechanism of prolonged intracellular TKI activity upon HD-TKI pulse-exposure (imatinib, dasatinib) in BCR-ABL-positive cells. Comprehensive mechanistic exploration revealed dramatic intracellular accumulation of TKIs which closely correlated with induction of apoptosis. Cells were rescued from apoptosis upon HD-TKI pulse either by repetitive drug wash-out or by overexpression of ABC-family drug transporters. Inhibition of ABCB1 restored sensitivity to HD-TKI pulse-exposure. Thus, our data provide evidence that intracellular drug retention crucially determines biological activity of imatinib and dasatinib. These studies may refine our current thinking on critical requirements of TKI dose and duration of target inhibition for biological activity of TKIs. |
Keywords: | Cell Line, Tumor Intracellular Space Humans Benzamides Piperazines Pyrimidines Proto-Oncogene Proteins c-abl Annexin A5 ATP-Binding Cassette Transporters Protein Kinase Inhibitors Drug Screening Assays, Antitumor Signal Transduction Apoptosis Dose-Response Relationship, Drug Kinetics Time Factors Caspase 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive Imatinib Mesylate |
Rights: | Copyright: © 2012 Lipka et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
DOI: | 10.1371/journal.pone.0040853 |
Published version: | http://dx.doi.org/10.1371/journal.pone.0040853 |
Appears in Collections: | Aurora harvest 5 Medicine publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
hdl_73312.pdf | Published version | 1.74 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.